Compare CVR & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVR | OSRH |
|---|---|---|
| Founded | 1920 | N/A |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 11.7M |
| IPO Year | 1995 | N/A |
| Metric | CVR | OSRH |
|---|---|---|
| Price | $9.75 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.9K | ★ 707.2K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $27,890,260.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $8.15 | $0.38 |
| 52 Week High | $15.00 | $2.72 |
| Indicator | CVR | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 30.91 | 53.31 |
| Support Level | $8.78 | $0.51 |
| Resistance Level | $14.61 | $0.74 |
| Average True Range (ATR) | 0.59 | 0.06 |
| MACD | -0.40 | 0.02 |
| Stochastic Oscillator | 13.09 | 54.04 |
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.